Linglongjiuhuo Linglong Moxibustion Wormwood Moxibustion Patch
Herbal Moxibustion
Shanghai Jingqin Biological Technology Co., Ltd.
Human Otc Drug
NDC 73510-526Linglongjiuhuo Linglong Moxibustion Wormwood Moxibustion Patch also known as Herbal Moxibustion is a human otc drug labeled by 'Shanghai Jingqin Biological Technology Co., Ltd.'. National Drug Code (NDC) number for Linglongjiuhuo Linglong Moxibustion Wormwood Moxibustion Patch is 73510-526. This drug is available in dosage form of Tape. The names of the active, medicinal ingredients in Linglongjiuhuo Linglong Moxibustion Wormwood Moxibustion Patch drug includes Butylene Glycol - .2 g/g . The currest status of Linglongjiuhuo Linglong Moxibustion Wormwood Moxibustion Patch drug is Active.
Drug Information:
| Drug NDC: | 73510-526 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Linglongjiuhuo Linglong Moxibustion Wormwood Moxibustion Patch |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Herbal Moxibustion |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Shanghai Jingqin Biological Technology Co., Ltd. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Tape |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | BUTYLENE GLYCOL - .2 g/g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | CUTANEOUS
EXTRACORPOREAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 17 Oct, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 14 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Shanghai Jingqin Biological Technology Co., Ltd.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 3XUS85K0RA
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 73510-526-20 | 1 BAG in 1 BOX (73510-526-20) / 10 PACKET in 1 BAG (73510-526-11) / 1 g in 1 PACKET (73510-526-01) | 17 Oct, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose it is a heat disposable paster incorporating chemicals that provides heat therapy for body.
Product Elements:
Linglongjiuhuo linglong moxibustion wormwood moxibustion patch herbal moxibustion hydroxyethyl cellulose (280 mpa.s at 2%) water phenoxyethanol polyethylene glycol 300000 chlorphenesin butylene glycol butylene glycol
Indications and Usage:
Indications & usage pain relief, hot release, warming uterus, hemostatic, can be used to improve the conditioning neck, back, hands and feet and other rheumatism pain and spleen and stomach caused by cold injury, deficiency diarrhea and other conditions.
Warnings:
Warnings [warnings] this product is a disposable product for external use and cannot be taken orally. keep out of reach of children. [contraindications] pregnant women, diabetics, skin ulcers, and acute bleeding disorders are prohibited.
Do Not Use:
Warnings [warnings] this product is a disposable product for external use and cannot be taken orally. keep out of reach of children. [contraindications] pregnant women, diabetics, skin ulcers, and acute bleeding disorders are prohibited.
When Using:
When using conditioning neck, back, hands and feet and other rheumatism pain and spleen and stomach caused by cold injury, deficiency diarrhea and other conditions.
Dosage and Administration:
Dosage & administration 1 piece at a time; once a day.
Stop Use:
Stop use if irritation or discomfort occurs, discontinue the use and consult a physician.
Dosage Forms and Strength:
Dosage forms & strengths its dosage form is patch. 1 piece at a time; once a day. the active ingredient strength is 20% w/w.
Package Label Principal Display Panel:
Package label. principal display panel 01 11 20
Further Questions:
Questions please contact with us at the phone number on the package when you have any questions.